CLOs on the Move

Pieris

www.pieris.com

 
Pieris Pharmaceuticals is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Pieris is listed on the NASDAQ and trades under the ticker symbol PIRS.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.pieris.com
  • 255 State Street 9th floor
    Boston, MA USA 02109
  • Phone: 857.246.8998

Executives

Name Title Contact Details
Ahmed Mousa
 Senior Vice President, Corporate Operations and General Counsel Profile
Ahmed Mousa
 Senior Vice President, Chief Business Officer and General Counsel Profile

Similar Companies

Keeps

Keeps is the first brand from Thirty Madison, which is rebuilding the healthcare experience for the modern consumer.

Viatris

Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.

CNS Healthcare

Providing mental health and substance use disorder services for children, youth, and adults. No insurance needed. #EndStigma

Draximage

Draximage is a Kirkland, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Breakthrough Behavior

Breakthrough Behavior provides applied behavior analysis (ABA) therapy, speech therapy, and psychological testing services to children and young adults with autism and other developmental disabilities.